CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Analyst Reco. Charles River Laboratories International, Inc. BOERSE MUENCHEN

Equities

RV6

US1598641074

Market Closed - BOERSE MUENCHEN Other stock markets 03:43:17 2024-06-19 pm EDT			5-day change	1st Jan Change
194.2 ^EUR	-0.10%		-0.72%	-9.39%

Jun. 17	Charles River Laboratories, Captain T Cell Enter Manufacturing Deal	MT
Jun. 17	Charles River Laboratories International, Inc and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell Therapy	CI

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Baird Adjusts Price Target on Charles River Laboratories International to $271 From $270	Jun. 13	MT
Mizuho Initiates Charles River Laboratories International With Neutral Rating, $235 Price Target	Jun. 07	MT
ANALYST RECOMMENDATIONS : Lyft, Amazon, Fedex, Xpo, Unilever...	Jun. 07
ANALYST RECOMMENDATIONS : American Airlines, Salesforce, Five Below, Tesla, Okta...	Jun. 06
TD Cowen Adjusts Price Target on Charles River Laboratories International to $228 From $260	May. 13	MT
JPMorgan Adjusts Price Target on Charles River Laboratories International to $270 From $280	May. 10	MT
Jefferies Adjusts Price Target on Charles River Laboratories International to $226 From $235	May. 10	MT
Evercore ISI Adjusts Price Target on Charles River Laboratories International to $265 From $300	May. 10	MT
Baird Adjusts Price Target on Charles River Laboratories International to $270 From $282	May. 10	MT
Zacks Investment Research Adjusts Charles River Laboratories International's Price Target to $259 From $278	Apr. 12	MT
Charles River Laboratories Signs Plasmid DNA Manufacturing Deal With Ship of Theseus	Apr. 04	MT
Deutsche Bank Raises Price Target on Charles River Laboratories to $300 From $275, Keeps Buy Rating	Mar. 22	MT
Argus Raises Price Target on Charles River Laboratories International to $290 From $200, Maintains Buy Rating	Mar. 18	MT
Deutsche Bank Raises Charles River Laboratories International Price Target to $275 From $245, Maintains Buy Rating	Feb. 16	MT
Morgan Stanley Raises Price Target on Charles River Laboratories International to $235 From $205, Keeps Equalweight Rating	Feb. 16	MT
TD Cowen Adjusts Charles River Laboratories International's PT to $260 From $193, Keeps Market Perform Rating	Feb. 15	MT
Stephens Adjusts Charles River Laboratories International's PT to $280 From $270, Keeps Overweight Rating	Feb. 15	MT
Citigroup Adjusts Price Target on Charles River Laboratories International to $250 From $215, Maintains Neutral Rating	Feb. 15	MT
UBS Adjusts Charles River Laboratories International Price Target to $290 From $270, Maintains Buy Rating	Feb. 15	MT
JPMorgan Adjusts Price Target on Charles River Laboratories International to $280 From $270, Maintains Overweight Rating	Feb. 15	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Charles River Laboratories International, Inc. BOERSE MUENCHEN

Equities

RV6

US1598641074

Analyst Reco.

Filters